Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026

Same author

The Special Sauce: Lessons in Leadership Development from the Sojourns Scholar Leadership Program.

Journal of palliative medicine·2026

Same author

Embedding Palliative Care Clinicians in ALS Teams Improves ALS Clinicians' Confidence in Their Patient Management and Satisfaction With Palliative Care.

Muscle & nerve·2026

Same author

"We Talk About Everything": Experiences with Digital Health Communication in Palliative Care.

Journal of palliative medicine·2026

Same author

If You Want to Go Far, Go Together: Lessons Learned from Quality Improvement Collaboratives in Palliative Care.

Journal of palliative medicine·2026

Same author

Impact of Virtual vs. In-Person Palliative Care on Symptom Burden: A Multisite Cohort Study.

Journal of pain and symptom management·2026

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Dyspnea in interstitial lung disease.

Harold R Collard¹, Steven Z Pantilat

¹Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA. hal.collard@ucsf.edu

Current Opinion in Supportive and Palliative Care

|August 8, 2008

Summary

Dyspnea, or shortness of breath, is common in interstitial lung disease (ILD) and often stems from breathing control issues. Management is challenging, with pulmonary rehabilitation showing promise for improving quality of life.

Related Experiment Videos

Last Updated: Jul 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

Pulmonology
Respiratory Medicine
Clinical Science

Background:

Dyspnea is a prevalent and debilitating symptom in interstitial lung disease (ILD).
The underlying causes and optimal management strategies for dyspnea in ILD patients remain incompletely understood.
Understanding dyspnea in ILD is critical for improving patient outcomes and quality of life.

Purpose of the Study:

To review the current understanding of dyspnea in interstitial lung disease.
To summarize the established metrics for dyspnea measurement in ILD.
To discuss current and emerging management approaches for dyspnea in ILD.

Main Methods:

Literature review of existing studies on dyspnea in interstitial lung disease.
Analysis of neuromechanical abnormalities contributing to dyspnea.
Evaluation of current therapeutic interventions and their efficacy.

Main Results:

Dyspnea is nearly universal in ILD, primarily driven by neuromechanical abnormalities.
Established metrics effectively measure dyspnea severity, which correlates with quality of life and survival.
Pharmacological treatments lack proven efficacy; pulmonary rehabilitation offers therapeutic potential.
Addressing physical and psychiatric comorbidities is crucial for managing dyspnea.

Conclusions:

Dyspnea is a persistent and challenging symptom for individuals with interstitial lung disease.
Current management strategies are limited, highlighting the need for further research.
Effective treatment of dyspnea in ILD requires a multifaceted approach.